Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)
China · Delayed Price · Currency is CNY 45.38
+1.94 (4.47%)
Jul 31, 2026, 3:04 PM CST
SHE:300049 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 1,625 | 1,595 | 1,349 | 1,154 | 1,009 | 898.48 |
Revenue Growth | 19.79% | 18.26% | 16.93% | 14.37% | 12.27% | 11.26% |
Gross Profit Gross Profit Growth | 1,211 | 1,195 | 998.28 | 862.34 | 741.09 | 659.34 |
Operating Income Operating Income Growth | 401.95 | 399.56 | 286.89 | 240.34 | 178.41 | 167.4 |
Net Income Net Income Growth | 157.25 | 154.09 | 113.29 | 101.56 | 97.89 | 95.47 |
Earnings Per Share EPS Growth | 0.59 | 0.58 | 0.43 | 0.39 | 0.37 | 0.37 |
EPS Growth | 56.10% | 34.88% | 11.37% | 3.76% | 1.22% | 52.22% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Inter-Segment Elimination Inter-Segment Elimination Growth | -0.21 |
Equipment and Technology Division Equipment and Technology Division Growth | 1,134 |
Pharmaceuticals and Services Division Pharmaceuticals and Services Division Growth | 461.99 |
Total Total Growth | 1,595 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 749.08 | 733.36 | 724.33 | 603.7 | 615.41 | 618.52 |
Total Debt Total Debt Growth | 79.96 | 93.17 | 76.42 | 59.34 | 55.68 | 108.36 |
Net Cash (Debt) Net Cash Growth | 669.12 | 640.19 | 647.91 | 544.36 | 559.73 | 510.17 |
Net Cash Growth | 2.39% | -1.19% | 19.02% | -2.75% | 9.72% | 31.30% |
Net Cash Per Share Net Cash Per Share Growth | 2.51 | 2.41 | 2.46 | 2.07 | 2.13 | 1.96 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 367.88 | 351.53 | 221.41 | 304.89 | 189.46 | 222.55 |
Capital Expenditures CapEx Growth | -182.48 | -189.01 | -218.97 | -189.23 | -90.78 | -79.61 |
Free Cash Flow Free Cash Flow Growth | 185.4 | 162.51 | 2.44 | 115.66 | 98.69 | 142.94 |
Free Cash Flow Growth | 747.32% | 6555.09% | -97.89% | 17.20% | -30.96% | 58.11% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 74.52% | 74.91% | 74.00% | 74.74% | 73.47% | 73.38% |
Operating Margin | 24.73% | 25.05% | 21.27% | 20.83% | 17.69% | 18.63% |
Pretax Margin | 22.37% | 21.97% | 20.06% | 20.40% | 19.00% | 21.05% |
Profit Margin | 9.68% | 9.66% | 8.40% | 8.80% | 9.70% | 10.63% |
FCF Margin | 11.41% | 10.19% | 0.18% | 10.03% | 9.78% | 15.91% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 |
Dividend Per Share Dividend Per Share Growth | 0.015 | 0.015 | - | - | 0.200 |
Dividend Per Share Growth | 0% | - | - | - | - |
Dividend Yield | 0.03% | 0.02% | - | - | 0.83% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 77.00 | 121.08 | 74.16 | 112.90 | 65.65 | 39.47 |
Forward PE | 41.25 | 69.97 | 34.56 | 64.69 | 29.24 | 29.24 |
P/FCF Ratio | 64.62 | 114.80 | 3440.21 | 99.14 | 65.12 | 26.36 |
PS Ratio | 7.37 | 11.69 | 6.23 | 9.94 | 6.37 | 4.19 |